Links & Summaries to 5 New Articles on Hepatitis C subjects

[Guest guest]

Compass Biotechnologies, Inc. Seeking Drugs to Fight and Prevent HCV Infection

Sacramento Bee

" The Hepatitis C Vaccine market potential for Compass is approximately US$2

billion, but with the development of a second anti HCV type product based on new

scientific findings that augments to make a HCV vaccine even more potent, then

this means that ...

See all stories on this topic »Nevada Hepatitis C Doctor Ruled Competent for

Trial

OutpatientSurgery.net

The latest twist in a case full of them finds a Las Vegas doctor accused of

exposing patients to hepatitis C ruled competent to stand trial. Despite

initially being found incompetent due to the effects of 2 strokes suffered in

recent years, ...

See all stories on this topic » Inmates 'denied' hepatitis care: Libs

The Canberra Times

BY HENRIETTA COOK ACT prisoners face inadequate health care with one-third of

hepatitis C-infected inmates waiting for treatment, according to the Canberra

Liberals. On August 22, there were 33 prisoners in the Maconochie

Centre waiting for ...

See all stories on this topic »

Enanta's Lead NS5A Inhibitor Candidate for HCV, EDP-239, Selected as One of ...

PR Newswire (press release)

26, 2011 /PRNewswire/ -- Enanta Pharmaceuticals, Inc. announced today that its

lead development candidate from its NS5A hepatitis C virus (HCV) inhibitor

program, EDP-239, has been recognized on Windhover's list of the " Top 10 Most

Interesting ...

See all stories on this topic » Cole To Spotlight Hepatitis C Campaign

Look To The Stars

Grammy winner Cole, who was diagnosed with chronic hepatitis C in 2008,

will meet with leading patient advocates in Washington, DC, and discuss the Tune

In to Hep C national public health initiative, sponsored by Merck and the

American Liver ...

See all stories on this topic »

[Guest guest]

Compass Biotechnologies, Inc. Seeking Drugs to Fight and Prevent HCV Infection

Sacramento Bee

" The Hepatitis C Vaccine market potential for Compass is approximately US$2

billion, but with the development of a second anti HCV type product based on new

scientific findings that augments to make a HCV vaccine even more potent, then

this means that ...

See all stories on this topic »Nevada Hepatitis C Doctor Ruled Competent for

Trial

OutpatientSurgery.net

The latest twist in a case full of them finds a Las Vegas doctor accused of

exposing patients to hepatitis C ruled competent to stand trial. Despite

initially being found incompetent due to the effects of 2 strokes suffered in

recent years, ...

See all stories on this topic » Inmates 'denied' hepatitis care: Libs

The Canberra Times

BY HENRIETTA COOK ACT prisoners face inadequate health care with one-third of

hepatitis C-infected inmates waiting for treatment, according to the Canberra

Liberals. On August 22, there were 33 prisoners in the Maconochie

Centre waiting for ...

See all stories on this topic »

Enanta's Lead NS5A Inhibitor Candidate for HCV, EDP-239, Selected as One of ...

PR Newswire (press release)

26, 2011 /PRNewswire/ -- Enanta Pharmaceuticals, Inc. announced today that its

lead development candidate from its NS5A hepatitis C virus (HCV) inhibitor

program, EDP-239, has been recognized on Windhover's list of the " Top 10 Most

Interesting ...

See all stories on this topic » Cole To Spotlight Hepatitis C Campaign

Look To The Stars

Grammy winner Cole, who was diagnosed with chronic hepatitis C in 2008,

will meet with leading patient advocates in Washington, DC, and discuss the Tune

In to Hep C national public health initiative, sponsored by Merck and the

American Liver ...

See all stories on this topic »